Pancreatic Cancer News
The daily pancreatic cancer news is a unique cancer news service that evaluates all aspects of pancreatic cancer research and reports on the developments that are most important to cancer patients and health care providers. The daily cancer news provides information about emerging options for pancreatic cancer prevention, early detection and pancreatic cancer treatment, as well as advances in supportive care and personalized medicine. Supportive care improves quality of life by making pancreatic cancer treatment more tolerable, and personalized medicine offers the potential for improved treatment outcomes by using specific characteristics of the patient or the cancer to guide cancer treatment decisions. In addition, interested individuals can search the Cancer Consultants Pancreatic Cancer News Archives to find the results of the cancer studies that led to the care they have been offered.
Pancreatic Cancer News
Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)
People who follow the diet and lifestyle recommendations laid out by the World Cancer Research Fund (WCRF) and the American Institute for Cancer Research (AICR) have a 34 percent reduced risk of dying... Continue Reading
Abraxane® (nab-paclitaxel) prolonged life in patients with metastatic pancreatic cancer by an average of two months longer than chemotherapy and significantly increased the percentage of patients who... Continue Reading
Overall cancer death rates continue to decline in both men and women and across major ethnic and racial groups, according to the annual Status of Cancer report published in the Journal of the National... Continue Reading
Two million cancer cases each year—or roughly 16 percent of cancers worldwide—are the result of preventable and treatable infections such as human papillomavirus (HPV) and Hepatitis C (HCV), according... Continue Reading
A combined analysis of 51 randomized trials found that daily aspirin use reduces the risk of new cancer diagnoses as well as the risk of cancer death. These results were published in The Lancet. A growing... Continue Reading
A study of families with Lynch Syndrome has expanded the list of cancers related to the condition: carriers of a Lynch Syndrome gene mutation also appear to have an increased risk of breast cancer and... Continue Reading
A test that detects a particular protein in the blood (PAM4) correctly identified roughly two-thirds of patients with early-stage pancreatic cancer. These results were presented at the 2012 Gastrointestinal... Continue Reading
Eating processed meat such as sausage or bacon appears to increase the risk of pancreatic cancer. These results were published in the British Journal of Cancer. Pancreatic cancer is one of the deadliest... Continue Reading
Live Web Chat with Barrie R. Cassileth, PhD, Chief, Integrative Medicine Service; Laurance S. Rockefeller Chair Integrative Medicine, Memorial Sloan-Kettering Cancer Center (MSKCC), click here for Dr.... Continue Reading
Picking the Cancer Treatment That Works Best for You- Ask the Expert about Personalized Medicine Live Web Chat with David Sidransky, MD, Johns Hopkins Medicine, Baltimore, MD, click here for bio Dr.... Continue Reading
Latest Pancreatic Cancer News By Stage
Screening and Prevention
Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)
A combined analysis of 51 randomized trials found that daily aspirin use reduces the risk of new cancer diagnoses as well as the risk of cancer death. These results were published in The Lancet. A growing body of evidence suggests that aspirin may reduce... Continue Reading
Lynch Syndrome Also Linked with Breast and Pancreatic Cancer (February 17, 2012)A study of families with Lynch Syndrome has expanded the list of cancers related to the condition: carriers of a Lynch Syndrome gene mutation also appear to have an increased risk of breast cancer and pancreatic cancer. These results were published in... Continue Reading
Test Holds Promise for Early Detection of Pancreatic Cancer (January 24, 2012)A test that detects a particular protein in the blood (PAM4) correctly identified roughly two-thirds of patients with early-stage pancreatic cancer. These results were presented at the 2012 Gastrointestinal Cancers Symposium. Pancreatic cancer is one... Continue Reading
Processed Meat Linked with Increased Risk of Pancreatic Cancer (January 18, 2012)Eating processed meat such as sausage or bacon appears to increase the risk of pancreatic cancer. These results were published in the British Journal of Cancer. Pancreatic cancer is one of the deadliest forms of cancer. Each year, close to 44,000 people... Continue Reading
Stay on Top of Your Family History of Cancer (July 15, 2011)People who are at high risk of cancer as a result of their family history may be advised to undergo earlier or more intensive cancer screening. Because family history of cancer can change over time, it’s important to update this information periodically... Continue Reading
More Screening and PreventionStages I-III
Sutent Approved for Pancreatic Neuroendocrine Tumors (PNET) (June 2, 2011)
The US Food and Drug Administration has approved the targeted drug Sutent® (sunitinib) for the treatment pancreatic neuroendocrine tumors (PNET). Pancreatic neuroendocrine tumors are an uncommon type of cancer that develops in the hormone-producing cells... Continue Reading
Afinitor Approved for Pancreatic Neuroendocrine Tumors (May 10, 2011)The US Food and Drug Administration has approved Afinitor® (everolimus) for the treatment of advanced pancreatic neuroendocrine tumors (PNET). Pancreatic neuroendocrine tumors are a relatively uncommon type of cancer that develops in the hormone-producing... Continue Reading
New Approach to Immune Therapy Shows Promise against Pancreatic Cancer (April 1, 2011)An investigational type of immune therapy that attacks the tissue around a tumor has shown promise in a small study of patients with advanced pancreatic cancer. These results were published in the journal Science. Immune therapies stimulate the body’s... Continue Reading
Addition of Axitinib Fails to Improve Pancreatic Cancer Outcomes (February 23, 2011)Among patients with advanced pancreatic cancer, treatment with a combination of Gemzar® (gemcitabine) and the investigational drug axitinib did not result in better outcomes than treatment with Gemzar alone. The results of this Phase III clinical trial... Continue Reading
Gemzar Versus 5-FU for Adjuvant Treatment of Pancreatic Cancer (September 21, 2010)A large randomized study demonstrated no significant improvement in survival with Gemzar® (gemcitabine) versus 5-fluorouracil (5-FU) for the adjuvant (post-surgery) treatment of pancreatic cancer. These findings were recently published in the Journal... Continue Reading
More Stages I and IIIStage IV
Abraxane Improves Survival in Pancreatic Cancer (February 13, 2013)
Abraxane® (nab-paclitaxel) prolonged life in patients with metastatic pancreatic cancer by an average of two months longer than chemotherapy and significantly increased the percentage of patients who survived for up to two years, according to the results... Continue Reading
Sutent Approved for Pancreatic Neuroendocrine Tumors (PNET) (June 2, 2011)The US Food and Drug Administration has approved the targeted drug Sutent® (sunitinib) for the treatment pancreatic neuroendocrine tumors (PNET). Pancreatic neuroendocrine tumors are an uncommon type of cancer that develops in the hormone-producing cells... Continue Reading
Novel Chemotherapy Regimen Outperforms Gemzar for Pancreatic Cancer (May 18, 2011)For people with metastatic pancreatic cancer, the chemotherapy combination known as FOLFIRINOX results in better overall survival than standard treatment with Gemzar® (gemcitabine), but also increases side effects. These results were published in the... Continue Reading
Afinitor Approved for Pancreatic Neuroendocrine Tumors (May 10, 2011)The US Food and Drug Administration has approved Afinitor® (everolimus) for the treatment of advanced pancreatic neuroendocrine tumors (PNET). Pancreatic neuroendocrine tumors are a relatively uncommon type of cancer that develops in the hormone-producing... Continue Reading
New Approach to Immune Therapy Shows Promise against Pancreatic Cancer (April 1, 2011)An investigational type of immune therapy that attacks the tissue around a tumor has shown promise in a small study of patients with advanced pancreatic cancer. These results were published in the journal Science. Immune therapies stimulate the body’s... Continue Reading
More Stage IVRecurrent
Study Evaluates Whole-brain Radiation Following Surgery or Radiosurgery in Cancer Spread to the Brain (November 16, 2010)
Results from a randomized Phase III study indicate that whole-brain radiation therapy (WBRT) following removal of one to three brain metastases with surgery or radiosurgery does not improve overall survival or duration of functional independence but does... Continue Reading
November Is National Pancreatic Cancer Awareness Month (November 5, 2009)As the month of November brings pancreatic cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated pancreatic... Continue Reading
Pancreatic Cancer Care Is Inconsistent (July 21, 2009)The quality of care for pancreatic cancer varies considerably among hospitals in the United States, according to the results of a study published in the Journal of the National Cancer Institute.[1] Pancreatic cancer has one of the highest mortality rates... Continue Reading
NCCN Updates Pancreatic Cancer Guidelines (December 12, 2007)NCCN Updates Pancreatic Cancer Guidelines The National Comprehensive Cancer Network (NCCN), an alliance of 21 leading cancer centers, has updated its guidelines regarding the care of pancreatic cancer patients. The updated guidelines include a new section... Continue Reading
GEMOX Active in Recurrent Pancreatic Cancer (February 24, 2006)GEMOX Active in Recurrent Pancreatic Cancer According to a an article recently published in the British Journal of Cancer, the chemotherapy combination consisting of Gemzar® (gemcitabine) plus Eloxatin® (oxaliplatin), referred to as GEMOX, has activity... Continue Reading
More Recurrent
